We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas.
- Authors
Martinho, Olga; Granja, Sara; Jaraquemada, Teresa; Caeiro, Cláudia; Miranda-Gonçalves, Vera; Honavar, Mrinalini; Costa, Paulo; Damasceno, Margarida; Rosner, Marsha R.; Lopes, José M.; Reis, Rui M.
- Abstract
Malignant gliomas are highly infiltrative and invasive tumors, which precludes the few treatment options available. Therefore, there is an urgent need to elucidate the molecular mechanisms underlying gliomas aggressive phenotype and poor prognosis. The Raf Kinase Inhibitory protein (RKIP), besides regulating important intracellular signaling cascades, was described to be associated with progression, metastasis and prognosis in several human neoplasms. Its role in the prognosis and tumourigenesis of gliomas remains unclear. In the present study, we found that RKIP protein is absent in a low frequency (10%, 20/193) of glioma tumors. Nevertheless, the absence of RKIP expression was an independent prognostic marker in glioma. Additionally, by in vitro downregulation of RKIP, we found that RKIP inhibition induces a higher viability and migration of the cells, having no effect on cellular proliferation and angiogenesis, as assessed by in vivo CAM assay. In conclusion, this is the largest series studied so far evaluating the expression levels of this important cancer suppressor protein in glioma tumors. Our results suggest that in a subset of tumors, the absence of RKIP associates with highly malignant behavior and poor survival of patients, which may be a useful biomarker for tailored treatment of glioma patients.
- Subjects
NERVOUS system tumors; MELANOMA; GLIOMAS; CELL proliferation; NEOVASCULARIZATION
- Publication
PLoS ONE, 2012, Vol 7, Issue 1, p1
- ISSN
1932-6203
- Publication type
Article
- DOI
10.1371/journal.pone.0030769